Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006; 44: 990–997. ArticlePubMed Google Scholar
Strayer DS, Akkina R, Bunnell BA, Dropulic B, Planelles V, Pomerantz RJ et al. Current status of gene therapy strategies to treat HIV/AIDS. Mol Ther 2005; 11: 823–842. ArticleCASPubMed Google Scholar
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806–811. ArticleCASPubMed Google Scholar
Wolkowicz R, Nolan GP . Gene therapy progress and prospects: novel gene therapy approaches for AIDS. Gene Therapy 2005; 12: 467–476. ArticleCASPubMed Google Scholar
Jacque JM, Triques K, Stevenson M . Modulation of HIV-1 replication by RNA interference. Nature 2002; 418: 435–438. ArticleCASPubMed Google Scholar
Das AT, Brummelkamp TR, Westerhout EM, Vink M, Madiredjo M, Bernards R et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004; 78: 2601–2605. ArticleCASPubMedPubMed Central Google Scholar
ter Brake O, Konstantinova P, Ceylan M, Berkhout B . Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 2006; 14: 883–892. ArticleCASPubMed Google Scholar
Chang LJ, Liu X, He J . Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene Therapy 2005; 12: 1133–1144. ArticleCASPubMed Google Scholar
Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B . HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005; 33: 796–804. ArticleCASPubMedPubMed Central Google Scholar
Lackner AA, Veazey RS . Current concepts in AIDS pathogenesis: insights from the SIV/macaque model. Annu Rev Med 2007; 58: 461–476. ArticleCASPubMed Google Scholar
Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J . The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004; 427: 848–853. ArticleCASPubMed Google Scholar
Dias AS, Bester MJ, Britz RF, Apostolides Z . Animal models used for the evaluation of antiretroviral therapies. Curr HIV Res 2006; 4: 431–446. ArticleCASPubMed Google Scholar
Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004; 304: 104–107. ArticleCASPubMed Google Scholar
Gimeno R, Weijer K, Voordouw A, Uittenbogaart CH, Legrand N, Alves NL et al. Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2−/− gammac−/− mice: functional inactivation of p53 in developing T cells. Blood 2004; 104: 3886–3893. ArticleCASPubMed Google Scholar
Legrand N, Weijer K, Spits H . Experimental models to study development and function of the human immune system in vivo. J Immunol 2006; 176: 2053–2058. ArticleCASPubMed Google Scholar
Manz MG . Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 2007; 26: 537–541. ArticleCASPubMed Google Scholar
Legrand N, Cupedo T, van Lent AU, Ebeli MJ, Weijer K, Hanke T et al. Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in ‘human immune system’ Rag2(−/−)gammac(−/−) mice. Blood 2006; 108: 238–245. ArticleCASPubMed Google Scholar
Baenziger S, Tussiwand R, Schlaepfer E, Mazzucchelli L, Heikenwalder M, Kurrer MO et al. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/−gamma c−/− mice. Proc Natl Acad Sci USA 2006; 103: 15951–15956. ArticleCASPubMedPubMed Central Google Scholar
Zhang L, Kovalev GI, Su L . HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 2007; 109: 2978–2981. CASPubMedPubMed Central Google Scholar
Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y et al. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007; 109: 212–218. ArticleCASPubMed Google Scholar
Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R . HIV-1 infection and CD4 T cell depletion in the humanized Rag2−/− gamma c−/− (RAG-hu) mouse model. Retrovirology 2006; 3: 76. ArticlePubMedPubMed Central Google Scholar
An DS, Poon B, Ho Tsong FR, Weijer K, Blom B, Spits H et al. Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 2007; 14: 391–396. ArticleCASPubMedPubMed Central Google Scholar
Berges BK, Akkina SR, Folkvord JM, Connick E, Akkina R . Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2(−/−)gammac(−/−) (RAG-hu) mice. Virology 2008; 373: 342–351. ArticleCASPubMed Google Scholar
Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463–8471. CASPubMedPubMed Central Google Scholar
Seppen J, Rijnberg M, Cooreman MP, Oude Elferink RP . Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. J Hepatol 2002; 36: 459–465. ArticleCASPubMed Google Scholar
Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873–9880. CASPubMedPubMed Central Google Scholar
ter Brake O, Berkhout B . Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions. J Gene Med 2007; 9: 743–750. ArticleCASPubMed Google Scholar
Weijer K, Uittenbogaart CH, Voordouw A, Couwenberg F, Seppen J, Blom B et al. Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo. Blood 2002; 99: 2752–2759. ArticleCASPubMed Google Scholar
Anderson J, Li MJ, Palmer B, Remling L, Li S, Yam P et al. Safety and efficacy of a lentiviral vector containing three anti-HIV genes—CCR5 ribozyme, tat-rev siRNA, and TAR decoy—in SCID-hu mouse-derived T cells. Mol Ther 2007; 15: 1182–1188. ArticleCASPubMed Google Scholar
An DS, Donahue RE, Kamata M, Poon B, Metzger M, Mao SH et al. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc Natl Acad Sci USA 2007; 104: 13110–13115. ArticleCASPubMedPubMed Central Google Scholar
Grimm D, Kay MA . Combinatorial RNAi: a winning strategy for the race against evolving targets? Mol Ther 2007; 15: 878–888. ArticleCASPubMed Google Scholar
ter Brake O, t Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B . Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 2008; 16: 557–564. ArticleCASPubMed Google Scholar